CINDY ALTONBURG: Open Payments
NPI 1124722582 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,324 in 80 payments from 17 companies in 2025. Trend: 2023 $1,850 · 2024 $1,922 · 2025 $2,324
Food & beverage: $2,284Education: $40
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 25 | $1,078 |
| ABBVIE INC. | 14 | $306 |
| Janssen Biotech, Inc. | 10 | $220 |
| Sumitomo Pharma America, Inc. | 12 | $187 |
| Endo USA, Inc. | 2 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| PFIZER INC. | 2 | $48 |
| Olympus America Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Procept Biorobotics Corporation | 1 | $31 |
Products named: INTERSTIM, BOTOX, XIAFLEX, ERLEADA, RYBREVANT, GEMTESA, ORGOVYX, Nubeqa.
Industry payments across TX — which companies pay providers there.
